Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
|
US |
|
A
|
AsiaPhos Ltd
SGX:5WV
|
SG |
|
Knowit AB (publ)
STO:KNOW
|
SE |
|
B
|
BW Ideol AS
OSE:BWIDL
|
NO |
|
A
|
Administer Oy
OMXH:ADMIN
|
FI |
|
W
|
Wanted Lab Inc
KOSDAQ:376980
|
KR |
|
A
|
AppTech Payments Corp
NASDAQ:APCX
|
US |
|
F
|
Ftai Infrastructure Inc
NASDAQ:FIP
|
US |
|
illimity Bank SpA
MIL:ILTY
|
IT |
|
Omni Bridgeway Ltd
ASX:OBL
|
AU |
Wall Street
Price Targets
CPRX Price Targets Summary
Catalyst Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CPRX
is 35.02 USD
with a low forecast of 32.32 USD and a high forecast of 37.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CPRX's stock price target?
Price Target
35.02
USD
According to Wall Street analysts, the average 1-year price target for
CPRX
is 35.02 USD
with a low forecast of 32.32 USD and a high forecast of 37.8 USD.
What is Catalyst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
9%
The
compound annual growth rate
of Catalyst Pharmaceuticals Inc's revenue for the next 3 years is
9%.
What is Catalyst Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
12%
The
compound annual growth rate
of Catalyst Pharmaceuticals Inc's operating income for the next 3 years is
12%.
What is Catalyst Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
6%
The
compound annual growth rate
of Catalyst Pharmaceuticals Inc's net income for the next 3 years is
6%.
